CG Oncology has filed with the U.S. Securities and Exchange Commission to raise $289,000,000.00 in an Initial Public Offering
According to filings with the U.S. Securities and Exchange Commission, CG Oncology is raising $289,000,000.00 in new funding. About CG Oncology: CG Oncology is a privately held oncolytic immunotherapy company focused on developing bladder-saving therapeutics…